Jobs
岗位职责:
- 参加GMP培训并遵循GMP规则在车间内完成生产任务;
- 负责执行细胞的复苏解冻,细胞在摇瓶和反应器中的扩增培养以及细胞在反应器阶段的生产和收获操作;
- 参与生产上游部门GMP相关文件的撰写、升版、执行;
- 及时上报并协助主管解决技术 转移、工艺放大及日常生产中遇到的问题,改进并优化生产流程及工作方法,定期进行总结和汇报;
- 参与生产人员的技术、设备、规范、工艺等相关文件的培训,并通过考核;
- 参与生产中出现的偏差、偏离、异常事件的调查和改进工作(偏差、变更、CAPA等);
- 与供应链部门、工程部门、QA部门、QC部门等相互合作,推进生产的顺利进行。
任职要求:
- 大专及以上学历;微生物、生物化学、生物制药和发酵工程等专业优先;
- 有1年及以上相关生物制药行业GMP工作经验者优先考虑;
- 熟悉上游生产设备的操作;
- GMP厂房的清洁和运行,物料管理和其他相关生产运营管理;
- 具有良好的沟通表达能力;
- 了解生物制药领域GMP的相关法规要求;
- 了解偏差发起、调查、关闭和CAPA执行的整个质量管控过程;
- 具备一定的英文阅读和书写能力,能够审阅GMP相关文件;
- 具有吃苦耐劳的品质和良好的身体素质,与积极向上持续学习的能力;
- 熟练使用Office、Visio等办公软件。
Total Views
0
Apply Clicks
0
Weekly mock applicants
0
Bookmarks
0
Similar jobs
About BioNTech

BioNTech
PublicBioNTech SE is a German multinational biotechnology company headquartered in Mainz that develops immunotherapies and vaccines, particularly for cancer and infectious diseases.
1,001-5,000
Employees
Mainz that develops immunotherapies
Headquarters
$21.7B
Valuation
Reviews
4.0
10 reviews
Work-life balance
2.5
Compensation
3.8
Culture
4.2
Career
3.5
Management
3.2
75%
Recommend to a friend
Pros
Innovative and cutting-edge projects
Great team and collaborative environment
Excellent benefits and flexible schedule
Cons
Long working hours and high workload
Fast-paced and high-pressure environment
Management and communication issues
Salary Ranges
70 data points
L2
L3
L4
L5
L6
Mid/L4
Intern
L2 · Data Scientist L2
0 reports
$53,767
total per year
Base
$21,507
Stock
$26,884
Bonus
$5,377
$37,637
$69,897
Interview experience
1 interviews
Difficulty
3.0
/ 5
Duration
14-28 weeks
Interview process
1
Application Review
2
HR Screen
3
Hiring Manager Interview
4
Panel Interview
5
Final Interview
6
Offer
Common questions
Behavioral/STAR
Technical Knowledge
Past Experience
Culture Fit
Problem Solving
News & Buzz
BioNTech’s BNT323 Achieves Strong Phase 2 Response Rates in Endometrial Cancer - Oncodaily
Oncodaily
News
·
Today
BioNTech And Boehringer Trial Adds Dimension To Small Cell Lung Cancer Story - simplywall.st
simplywall.st
News
·
3d ago
Biontech prepares FDA application after strong phase II results in endometrial cancer - medwatch.com
medwatch.com
News
·
6d ago
BioNTech and DualityBio report positive data for trastuzumab pamirtecan - Clinical Trials Arena
Clinical Trials Arena
News
·
6d ago




